Ryerson Holding Corp (RYI) officer reports new dividend RSU awards

Rhea-AI Filing Summary

Ryerson Holding Corp executive reports dividend-equivalent RSUs

An executive officer of Ryerson Holding Corp, serving as EVP, General Counsel and Chief HR Officer, reported routine equity compensation activity effective December 18, 2025. The filing shows three awards of dividend equivalent rights in the form of restricted stock units (RSUs) tied to prior RSU grants. These awards cover 21.474, 42.003, and 72.964 RSUs at a price of $0 per unit, reflecting additional stock units credited when cash dividends are paid on the company’s common shares.

The underlying RSUs were originally granted on March 31, 2023, March 31, 2024, and March 31, 2025, and the related RSUs and dividend equivalent rights are scheduled to vest on March 31, 2026, and in some cases also on March 31, 2027 and March 31, 2028, in accordance with their original terms.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Silver Mark S.

Role EVP, GC & Chief HR Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	21.474	$0.00	--
Grant/Award	Restricted Stock Units	42.003	$0.00	--
Grant/Award	Restricted Stock Units	72.964	$0.00	--

Holdings After Transaction: Restricted Stock Units — 2,985.357 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silver Mark S.

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/18/2025		A		21.474(2)		(3)	(3)	Common Stock	21.474	$0	2,985.357	D
Restricted Stock Units	(1)	12/18/2025		A		42.003(2)		(4)	(4)	Common Stock	42.003	$0	5,839.417	D
Restricted Stock Units	(1)	12/18/2025		A		72.964(2)		(5)	(5)	Common Stock	72.964	$0	10,143.886	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of December 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ryerson Holding Corp (RYI) disclose in this Form 4 filing?

The filing reports that a Ryerson Holding Corp executive received additional restricted stock units (RSUs) as dividend equivalent rights on existing RSU awards effective December 18, 2025.

Who is the reporting person in the Ryerson Holding Corp (RYI) Form 4?

The reporting person is an officer of Ryerson Holding Corp serving as EVP, General Counsel & Chief HR Officer, filing individually.

How many new restricted stock units were credited to the Ryerson (RYI) executive?

The executive was credited with dividend equivalent rights in the form of RSUs totaling 21.474, 42.003, and 72.964 units, each at a price of $0 per unit.

What are dividend equivalent rights on Ryerson (RYI) restricted stock units?

Dividend equivalent rights are additional RSUs that accrue when dividends are paid on the common shares underlying the RSUs. They vest and settle on the same schedule and terms as the related RSU awards.

When do the reported Ryerson (RYI) RSUs and dividend equivalent rights vest?

The dividend equivalent rights relate to RSUs granted on March 31, 2023, March 31, 2024, and March 31, 2025. These RSUs and associated dividend equivalents are scheduled to vest on March 31, 2026, and, for later grants, also on March 31, 2027 and March 31, 2028.

Did the Ryerson (RYI) executive pay cash for these restricted stock units?

No cash was paid for these units; the Form 4 shows a transaction price of $0 for each block of dividend equivalent RSUs, reflecting their nature as stock-based compensation.